{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:18:15Z","timestamp":1794107895366,"version":"4.8.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,23]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Atovaquone induces AML blast apoptosis and prolongs survival in AML xenografts. Atovaquone induces proapoptotic signaling and inhibits the mTOR pathway through upregulation of ATF4 and also suppresses OXPHOS.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000499","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:33:55Z","timestamp":1576755235000},"page":"4215-4227","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7292-2464","authenticated-orcid":false,"given":"Alexandra M.","family":"Stevens","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0170-9321","authenticated-orcid":false,"given":"Michael","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N.","family":"Heppler","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-7668","authenticated-orcid":false,"given":"Isidora","family":"To\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime O.","family":"Munoz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos S.","family":"Gaikwad","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terzah M.","family":"Horton","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Long","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Seashore","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maci C.","family":"Terrell","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raushan","family":"Rashid","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Krueger","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia E.","family":"Mangubat-Medina","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rice University, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-0789","authenticated-orcid":false,"given":"Zachary T.","family":"Ball","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rice University, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Sumazin","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Hamada","sequence":"additional","affiliation":[{"name":"Division of Molecular Biology, Institute for Genome Research, and"},{"name":"Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Oyadomari","sequence":"additional","affiliation":[{"name":"Division of Molecular Biology, Institute for Genome Research, and"},{"name":"Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-3703","authenticated-orcid":false,"given":"Michele S.","family":"Redell","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-8364","authenticated-orcid":false,"given":"David A.","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"issue":"6","key":"2019121911323776100_B1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pbc.24432","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: acute myeloid leukemia","volume":"60","author":"Gamis","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"2019121911323776100_B2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2015-07-660506","article-title":"Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent","volume":"128","author":"Xiang","year":"2016","journal-title":"Blood"},{"key":"2019121911323776100_B3","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat Commun"},{"issue":"23","key":"2019121911323776100_B4","doi-asserted-by":"crossref","first-page":"34084","DOI":"10.18632\/oncotarget.9122","article-title":"Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells","volume":"7","author":"Fiorillo","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"2019121911323776100_B5","doi-asserted-by":"crossref","first-page":"e22195","DOI":"10.1002\/jbt.22195","article-title":"Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy","volume":"32","author":"Chen","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"issue":"22","key":"2019121911323776100_B6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.899.899","article-title":"The addition of bortezomib to standard chemotherapy for pediatric acute myeloid leukemia has increased toxicity without therapeutic benefit: a report from the Children\u2019s Oncology Group","volume":"128","author":"Aplenc","year":"2016","journal-title":"Blood."},{"issue":"27","key":"2019121911323776100_B7","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.2014.55.3628","article-title":"Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children\u2019s Oncology Group trial AAML0531","volume":"32","author":"Gamis","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019121911323776100_B8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bjh.13492","article-title":"Stromal CYR61 confers resistance to mitoxantrone via spleen tyrosine kinase activation in human acute myeloid leukaemia","volume":"170","author":"Long","year":"2015","journal-title":"Br J Haematol"},{"issue":"21","key":"2019121911323776100_B9","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1182\/blood-2010-04-280123","article-title":"Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor","volume":"117","author":"Redell","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019121911323776100_B10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"2019121911323776100_B11","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2019121911323776100_B12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"310","key":"2019121911323776100_B13","doi-asserted-by":"crossref","first-page":"ra11","DOI":"10.1126\/scisignal.2004497","article-title":"STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-\u03baB to IL-6 signaling axis and STAT3-driven cancer phenotypes","volume":"7","author":"Xiang","year":"2014","journal-title":"Sci Signal"},{"issue":"52","key":"2019121911323776100_B14","doi-asserted-by":"crossref","first-page":"90037","DOI":"10.18632\/oncotarget.21363","article-title":"Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children\u2019s Oncology Group report","volume":"8","author":"Long","year":"2017","journal-title":"Oncotarget"},{"issue":"1-2","key":"2019121911323776100_B15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"issue":"1","key":"2019121911323776100_B16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"issue":"2","key":"2019121911323776100_B17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"DeYoung","year":"2008","journal-title":"Genes Dev"},{"issue":"1","key":"2019121911323776100_B18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","article-title":"CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade","volume":"182","author":"Mungrue","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"2019121911323776100_B19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2008.12.079","article-title":"ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression","volume":"379","author":"Whitney","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"2019121911323776100_B20","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00018-012-1252-6","article-title":"The eIF2\u03b1 kinases: their structures and functions","volume":"70","author":"Donnelly","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2019121911323776100_B21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2017.01.007","article-title":"The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma","volume":"55","author":"Burwick","year":"2017","journal-title":"Leuk Res"},{"issue":"7","key":"2019121911323776100_B22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2217\/fon.13.49","article-title":"Control of oncogenesis by eIF2\u03b1 phosphorylation: implications in PTEN and PI3K-Akt signaling and tumor treatment","volume":"9","author":"Koromilas","year":"2013","journal-title":"Future Oncol"},{"issue":"5","key":"2019121911323776100_B23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4161\/cc.27726","article-title":"Evidence for eIF2\u03b1 phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications","volume":"13","author":"Krishnamoorthy","year":"2014","journal-title":"Cell Cycle"},{"issue":"9","key":"2019121911323776100_B24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nchembio.613","article-title":"Chemical genetics identify eIF2\u03b1 kinase heme-regulated inhibitor as an anticancer target","volume":"7","author":"Chen","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"6","key":"2019121911323776100_B25","doi-asserted-by":"crossref","first-page":"e1002760","DOI":"10.1371\/journal.pgen.1002760","article-title":"Protective coupling of mitochondrial function and protein synthesis via the eIF2\u03b1 kinase GCN-2","volume":"8","author":"Baker","year":"2012","journal-title":"PLoS Genet"},{"issue":"11","key":"2019121911323776100_B26","doi-asserted-by":"crossref","first-page":"e1511","DOI":"10.1038\/cddis.2014.469","article-title":"A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4","volume":"5","author":"Evstafieva","year":"2014","journal-title":"Cell Death Dis"},{"issue":"9","key":"2019121911323776100_B27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1021\/np200370z","article-title":"Mitochondrial respiration inhibitors suppress protein translation and hypoxic signaling via the hyperphosphorylation and inactivation of translation initiation factor eIF2\u03b1 and elongation factor eEF2","volume":"74","author":"Li","year":"2011","journal-title":"J Nat Prod"},{"issue":"3","key":"2019121911323776100_B28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells","volume":"67","author":"Little","year":"2007","journal-title":"Cancer Res"},{"issue":"7","key":"2019121911323776100_B29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1582-4934.2011.01401.x","article-title":"Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells","volume":"16","author":"Liu","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2019121911323776100_B30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","article-title":"Roles of CHOP\/GADD153 in endoplasmic reticulum stress","volume":"11","author":"Oyadomari","year":"2004","journal-title":"Cell Death Differ"},{"issue":"4","key":"2019121911323776100_B31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/1535-7163.MCT-09-0988","article-title":"Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells","volume":"9","author":"Rao","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"2019121911323776100_B32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2008.05.138","article-title":"Induction of the endoplasmic reticulum stress protein GADD153\/CHOP by capsaicin in prostate PC-3 cells: a microarray study","volume":"372","author":"S\u00e1nchez","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2019121911323776100_B33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10495-005-3088-0","article-title":"Role of the unfolded protein response in cell death","volume":"11","author":"Kim","year":"2006","journal-title":"Apoptosis"},{"issue":"7","key":"2019121911323776100_B34","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/en.2006-1564","article-title":"Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells","volume":"148","author":"Wang","year":"2007","journal-title":"Endocrinology"},{"issue":"8","key":"2019121911323776100_B35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Guertin","year":"2005","journal-title":"Trends Mol Med"},{"issue":"7","key":"2019121911323776100_B36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"6","key":"2019121911323776100_B37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ijc.28261","article-title":"Molecular-targeted agents combination therapy for cancer: developments and potentials","volume":"134","author":"Li","year":"2014","journal-title":"Int J Cancer"},{"issue":"3","key":"2019121911323776100_B38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-121-3-199408010-00003","article-title":"Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS","volume":"121","author":"Dohn","year":"1994","journal-title":"Ann Intern Med"},{"issue":"22","key":"2019121911323776100_B39","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1056\/NEJM199111283252202","article-title":"A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome","volume":"325","author":"Falloon","year":"1991","journal-title":"N Engl J Med"},{"issue":"21","key":"2019121911323776100_B40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"Hughes","year":"1993","journal-title":"N Engl J Med"},{"issue":"9","key":"2019121911323776100_B41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2019121911323776100_B42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.42.6.1315","article-title":"Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children","volume":"42","author":"Hughes","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2019121911323776100_B43","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cncr.22562","article-title":"Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia","volume":"109","author":"Madden","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"2019121911323776100_B44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s002800000250","article-title":"The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia","volume":"47","author":"van de Poll","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"2019121911323776100_B45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/infdis\/163.4.843","article-title":"Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men","volume":"163","author":"Hughes","year":"1991","journal-title":"J Infect Dis"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/24\/4215\/1549441\/advancesadv2019000499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/24\/4215\/1549441\/advancesadv2019000499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:34:24Z","timestamp":1576755264000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/24\/4215\/429969\/Atovaquone-is-active-against-AML-by-upregulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":45,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,12,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000499","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]}}}